---
title: "ENDRA生命科学 (NDRA.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/NDRA.US/norm.md"
symbol: "NDRA.US"
name: "ENDRA生命科学"
parent: "https://longbridge.com/zh-CN/quote/NDRA.US.md"
datetime: "2026-03-03T19:40:08.518Z"
locales:
  - [en](https://longbridge.com/en/quote/NDRA.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NDRA.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NDRA.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/NDRA.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/NDRA.US/norm.md)


# ENDRA生命科学 (NDRA.US) — 财务报表

## 利润表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -2.10 | -1.71 | -1.86 | -7.69 | -9.54 |
| ROE | -776.37% | -304.00% | -192.21% | -362.16% | -120.73% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -1.60M | -1.23M | -1.04M | -4.15M | -2.35M |
| 营业利润 | -1.37M | -1.30M | -1.47M | -4.30M | -1.51M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 1.96M | 2.81M | 3.17M | 4.45M | 8.38M |
| 权益乘数 | 11.46 | 1.91 | 1.81 | 1.74 | 1.27 |
| 每股净资产 | 0.2178 | 1.96 | 3.12 | 4.77 | 12.35 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 794036.00 | 1.81M | 2.06M | 3.23M | 4.75M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 543996.00 | 583385.00 | 618991.00 | 647294.00 | 310052.00 |
| 净债务 | -268708.00 | -1.25M | -1.48M | -2.48M | -4.30M |

## 现金流量表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -1.16M | -1.11M | -1.29M | -1.52M | -1.66M |
| 投资现金流 | 0.0000 | 0.0000 | -17280.00 | 0.0000 | 0.0000 |
| 融资现金流 | 149466.00 | 857415.00 | 145803.00 | 0.0000 | 1683.00 |
| 自由现金流 | -659346.00 | -632134.00 | -616984.00 | -2.60M | -1.27M |
| 现金流充裕率 | - | - | -7483.39% | - | - |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | 0.0000 | 0.0000 | -17280.00 | 0.0000 | 0.0000 |